1. Home
  2. ONCY
  3. ONCY News

Latest Oncolytics Biotech Inc. (ONCY) News on November 28, 2025

Oncolytics Biotech® Provides Update on Special Meeting of Shareholders
ONCY

Business Wire

8 days ago

Oncolytics Biotech® Provides Update on Special Meeting of Shareholders

ONCY

MT Newswires

9 days ago

Oncolytics Biotech Reaches FDA Alignment on Phase 3 Pancreatic Cancer Trial Design

All You Need to Know About Oncolytics Biotech (ONCY) Rating Upgrade to Buy
ONCY

Zacks

9 days ago

All You Need to Know About Oncolytics Biotech (ONCY) Rating Upgrade to Buy

Oncolytics Biotech® Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer
ONCY

Business Wire

9 days ago

Oncolytics Biotech® Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer

Amazon workers with disabilities sue tech giant, alleging systematic discrimination
ONCY

Yahoo Finance

20 days ago

Amazon workers with disabilities sue tech giant, alleging systematic discrimination

CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering
ONCY

GlobeNewswire

20 days ago

CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering

What to know if your travel plans are impacted by the FAA's flight cancellations
ONCY

Associated Press Finance

20 days ago

What to know if your travel plans are impacted by the FAA's flight cancellations

US Senators and Congress Members Love This AI Stock
ONCY

Insider Monkey

20 days ago

US Senators and Congress Members Love This AI Stock

Forget Nvidia (NVDA) – American Politicians Are Buying This Small AI Stock
ONCY

Insider Monkey

20 days ago

Forget Nvidia (NVDA) – American Politicians Are Buying This Small AI Stock

Minister Anandasangaree highlights Budget 2025's plan to build strong communities in Hamilton
ONCY

CNW Group

20 days ago

Minister Anandasangaree highlights Budget 2025's plan to build strong communities in Hamilton

ONCY

The Meadville Tribune, Pa.

20 days ago

Grounds for excitement: Two coffee shops opening soon

Parliamentary Secretary to the Treasury Board highlights budget investments to build Canada strong
ONCY

CNW Group

20 days ago

Parliamentary Secretary to the Treasury Board highlights budget investments to build Canada strong

Oncolytics Biotech® Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy
ONCY

Business Wire

24 days ago

Oncolytics Biotech® Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy

Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care
ONCY

PR Newswire

a month ago

Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care

Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada
ONCY

PR Newswire

a month ago

Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada

ONCY

MT Newswires

3 months ago

Oncolytics Says Pelareorep Drug Shows 'Strong Efficacy, Translational Data' in Metastatic Colorectal Cancer

Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions
ONCY

PR Newswire

3 months ago

Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions

ONCY

MT Newswires

6 months ago

Oncolytics Appoints Jared Kelly as Chief Executive

Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs
ONCY

CNW Group

6 months ago

Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs

ONCY

MT Newswires

6 months ago

Oncolytics Outline New Clinical Trial Data in Poster Presentation at ASCO Meeting

Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities
ONCY

CNW Group

6 months ago

Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities

Oncolytics Biotech Inc (ONCY) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...
ONCY

GuruFocus.com

6 months ago

Oncolytics Biotech Inc (ONCY) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...

Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum
ONCY

PR Newswire

6 months ago

Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
ONCY

PR Newswire

7 months ago

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

ONCY

MT Newswires

7 months ago

Oncolytics to Present New Pancreatic Cancer Data at Oncology Meeting Next Month

Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action
ONCY

PR Newswire

7 months ago

Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action

ONCY

MT Newswires

8 months ago

Oncolytics Up 1.5% in U.S. Pre-market as Funds Pelareorep's Ongoing Clinical Development

Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital
ONCY

CNW Group

8 months ago

Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital

Oncolytics Biotech® and Pelareorep Discussed During Recent H.C. Wainwright Key Opinion Leader Event on Oncolytic Immunotherapies in Breast and Pancreatic Cancers
ONCY

PR Newswire

8 months ago

Oncolytics Biotech® and Pelareorep Discussed During Recent H.C. Wainwright Key Opinion Leader Event on Oncolytic Immunotherapies in Breast and Pancreatic Cancers

ONCY

MT Newswires

9 months ago

RBC on Oncolytics's Phase 2 Breast Cancer Trial

Oncolytics Biotech Inc (ONCY) Q4 2024 Earnings Call Highlights: Promising Cancer Study Results ...
ONCY

GuruFocus.com

9 months ago

Oncolytics Biotech Inc (ONCY) Q4 2024 Earnings Call Highlights: Promising Cancer Study Results ...

ONCY

MT Newswires

9 months ago

Oncolytics Q4 Net Loss Doubles, Provides Pelareorep Update

Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024
ONCY

PR Newswire

9 months ago

Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024

Oncolytics Biotech (ONCY) Loses -9.34% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ONCY

Zacks

9 months ago

Oncolytics Biotech (ONCY) Loses -9.34% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
ONCY

PR Newswire

9 months ago

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights

Oncolytics Biotech® Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025
ONCY

CNW Group

9 months ago

Oncolytics Biotech® Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025

ONCY

MT Newswires

9 months ago

Oncolytics Biotech Receives German Clearance for Pancreatic Cancer Study

Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer
ONCY

PR Newswire

9 months ago

Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer

ONCY

MT Newswires

9 months ago

Oncolytics Biotech Gets Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
ONCY

PR Newswire

9 months ago

Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

ONCY

MT Newswires

10 months ago

Oncolytics Biotech CEO to Step Down Following Medical Leave of Absence

Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence
ONCY

CNW Group

10 months ago

Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence

Oncolytics Biotech And 2 Other Promising Penny Stocks On The TSX
ONCY

Simply Wall St.

10 months ago

Oncolytics Biotech And 2 Other Promising Penny Stocks On The TSX

Oncolytics Biotech (ONCY) Upgraded to Buy: What Does It Mean for the Stock?
ONCY

Zacks

10 months ago

Oncolytics Biotech (ONCY) Upgraded to Buy: What Does It Mean for the Stock?

ONCY

MT Newswires

10 months ago

Oncolytics Biotech to Present New Efficacy and Safety Data at ASCO Symposium

Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium
ONCY

CNW Group

10 months ago

Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium

German PEI approves enrolment in cohort 5 of Oncolytics’ pancreatic cancer trial
ONCY

Clinical Trials Arena

10 months ago

German PEI approves enrolment in cohort 5 of Oncolytics’ pancreatic cancer trial

ONCY

MT Newswires

10 months ago

Oncolytics Biotech Says German Regulatory Approval Received for Full Patient Enrollment in Pancreatic Cancer Study

ONCY

MT Newswires

10 months ago

Oncolytics Biotech Up 6.5% in U.S. Pre-Market as Germany Approves Continuing GOBLET Enrollment

Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data
ONCY

PR Newswire

10 months ago

Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data

Will Oncolytics Biotech (TSE:ONC) Spend Its Cash Wisely?
ONCY

Simply Wall St.

a year ago

Will Oncolytics Biotech (TSE:ONC) Spend Its Cash Wisely?

Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data
ONCY

PR Newswire

a year ago

Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data

ONCY

MT Newswires

a year ago

Oncolytics Biotech to Present "Promising" Pelareorep Data at ASCO GI Symposium

Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium
ONCY

PR Newswire

a year ago

Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium

ONCY

MT Newswires

a year ago

Oncolytics Biotech Competes Safety Phase Enrollment for GOBLET Trial's Pancreatic Cancer Cohort

Oncolytics Biotech® Reports Completion of Initial Safety Phase Enrollment for GOBLET Trial's New Pancreatic Cancer Cohort
ONCY

CNW Group

a year ago

Oncolytics Biotech® Reports Completion of Initial Safety Phase Enrollment for GOBLET Trial's New Pancreatic Cancer Cohort

Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
ONCY

GuruFocus.com

a year ago

Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

ONCY

MT Newswires

a year ago

Oncolytics Biotech Q3 Loss Narrows

Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights
ONCY

PR Newswire

a year ago

Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
ONCY

CNW Group

a year ago

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
ONCY

PR Newswire

a year ago

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights

ONCY Stock Up on Regulatory Update From Breast Cancer Program
ONCY

Zacks

a year ago

ONCY Stock Up on Regulatory Update From Breast Cancer Program

Oncolytics targets accelerated approval for oncolytic virus therapy
ONCY

Pharmaceutical Technology

a year ago

Oncolytics targets accelerated approval for oncolytic virus therapy

ONCY

MT Newswires

a year ago

Oncolytics Biotech Provides Clinical Updates

Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path
ONCY

CNW Group

a year ago

Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path

ONCY

MT Newswires

a year ago

Oncolytics Biotech Reports "Favorable" Results for BRACELET-1 Breast Cancer Study

Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study
ONCY

PR Newswire

a year ago

Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September
ONCY

PR Newswire

a year ago

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September
ONCY

CNW Group

a year ago

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

Sernova Corp. Announces Appointment of New Chief Executive Officer
ONCY

GlobeNewswire

a year ago

Sernova Corp. Announces Appointment of New Chief Executive Officer

Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference
ONCY

PR Newswire

a year ago

Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference

ONCY

MT Newswires

a year ago

Oncolytics Biotech Reports Q2 Loss of $7.5 Million

Oncolytics Biotech® Reports Second Quarter 2024 Financial Results and Operational Highlights
ONCY

CNW Group

a year ago

Oncolytics Biotech® Reports Second Quarter 2024 Financial Results and Operational Highlights

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation
ONCY

Simply Wall St.

a year ago

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights
ONCY

CNW Group

a year ago

Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights

ONCY

MT Newswires

a year ago

Oncolytics Biotech UP 1.9% In US Premarket Announces "Productive" FDA Type C Meeting on Metastatic Breast Cancer Program

Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program
ONCY

CNW Group

a year ago

Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program

ONCY

MT Newswires

a year ago

Oncolytics Biotech CEO Matt Coffey to Take Medical Leave of Absence

ONCY

MT Newswires

a year ago

Oncolytics Biotech President and CEO Coffey to Take Medical Leave of Absence

Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence
ONCY

PR Newswire

a year ago

Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence

Oncolytics doses first subject in pancreatic cancer trial
ONCY

Clinical Trials Arena

a year ago

Oncolytics doses first subject in pancreatic cancer trial

ONCY

MT Newswires

a year ago

Oncolytics Biotech Doses First Patient in Pelareorep Study Involving Modified FOLFIRINOX

Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer
ONCY

PR Newswire

a year ago

Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer

Oncolytics Biotech (ONCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
ONCY

Zacks

a year ago

Oncolytics Biotech (ONCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

ONCY

MT Newswires

2 years ago

Oncolytics Biotech Says ASCO Abstracts Highlight Pelareorep's Treatment Potential in Pancreatic Cancer

Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action
ONCY

CNW Group

2 years ago

Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
ONCY

PR Newswire

2 years ago

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

ONCY

MT Newswires

2 years ago

Oncolytics Biotech Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Pancreatic Cancer Trial

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
ONCY

CNW Group

2 years ago

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript
ONCY

Insider Monkey

2 years ago

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript

ONCY

MT Newswires

2 years ago

Oncolytics Biotech Reports a First-Quarter Loss of Near $7 Million

Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights
ONCY

PR Newswire

2 years ago

Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights

ONCY

MT Newswires

2 years ago

Oncolytics Biotech Receives German Regulatory Clearance to Evaluate Pelareorep with Modified Folfirinox in Pancreatic Cancer

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer
ONCY

CNW Group

2 years ago

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer
ONCY

PR Newswire

2 years ago

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
ONCY

PR Newswire

2 years ago

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
ONCY

CNW Group

2 years ago

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
ONCY

CNW Group

2 years ago

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
ONCY

PR Newswire

2 years ago

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
ONCY

PR Newswire

2 years ago

Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

Share on Social Networks: